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N-Acetylcysteine Enhances Cardiac HO-1 Protein Expression and
Antioxidant Capacity in Diabetic Rats
  **   Xiaowen Mao, M.D., Kwok Fu J. Ng, M.D., Michael G. Irwin, M.D., Paul M. Vanhoutte, M.D., Ph.D.,
Zhengyuan Xia, M.D., Ph.D.
Department of Anesthesiology, University of Hong Kong, Hong Kong, China; Department of Pharmacology
and Pharmacy, University of Hong Kong, Hong Kong, China
Introduction: The antioxidant N-acetylcysteine (NAC) restores volatile anesthetic isoflurane-induced
preconditioning against myocardial infarction in hyperglycemia (1). However, the mechanism whereby NAC
restores isoflurane preconditioning cardioprotection is unclear. Elevated heme oxygenase-1 (HO-1) leads to
improved postischaemic cardiac function in type 1 diabetes (2), and enhancement of cardiac antioxidant
capacity facilitates postischemic myocardial functional recovery (3). Therefore, we hypothesized that NAC
may increase cardiac antioxidant capacity by enhancing HO-1 expression in diabetes.
Methods: Control or streptozotozin-induced type 1 diabetic rats were either untreated (C, D) or treated with
NAC (1.5g/kg/day, D+NAC) delivered by oral gavage for four weeks. Myocardial tissue protein contents of
HO-1 and Cu/Zn Superoxide dismutase (Cu/Zn SOD) were determined using Western blotting. Myocardial
total SOD and catalase enzyme activities as well as levels of 15-F2t-isoprostane, a specific marker of
oxidative stress, were determined using an enzymatic immunoassay. The total antioxidant activity of
myocardial tissue was determined using a colorimetic assay. Data were analyzed using two-way analysis of
variance with Bonferroni corrections.
Results: Myocardial 15-F2t-isoprostane (IsoP) was increased in the diabetic myocardium and this was
accompanied by compensatory increases in HO-1 (1.5-fold in D vs. C, P<0.05) and Cu/Zn SOD
([start_en]223C;2-fold in D vs. C, P<0.01) protein expressions and an increase in myocardial total
antioxidant activity ([start_en]223C;1.6-fold in D vs. C, P<0.01). The total SOD and catalase activities were
also increased in D rats (P<0.05 vs. C). NAC treatment prevented the compensatory increases of Cu/Zn
SOD protein expression and increases in SOD and catalase activities (P>0.05, D-NAC vs. C; P<0.05,
D-NAC vs. D) but led to a further increase in myocardial HO-1 protein expression ([start_en]223C;2-fold in D
vs. C, P<0.05) that was coincident with a further increase in myocardial total antioxidant activity
([start_en]223C;2.1-fold in D vs. C, P<0.05).
Conclusions: N-acetylcysteine treatment preferably enhances HO-1 protein expression in the diabetic
myocardium, leading to increased endogenous myocardial antioxidant capacity. This may represent a
mechanism by which N-acetylcysteine restores the isoflurane-induced preconditioning leading to
cardioprotection in hyperglycemia.
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